Remedee Labs, has obtained medical device status in Europe for its millimeter wave endorphin stimulator wristband. This achievement marks a

Remedee Labs, a French start-up that specializes in non-pharmaceutical chronic pain management and just announced the positive results of its

February 1st, 2023 – Today, the French pharmaceutical company UPSA and the startup Remedee Labs are announcing the signature of

On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough

Remedee Labs, a Grenoble-based startup specializing in integrated chronic pain care centered on its unique endorphin stimulation technology, is joining

French health tech startup Remedee Labs, designer of the first endorphin stimulator for personal use, is hiring Gilles Litman to

MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Their mission

The challenge of measuring endorphin levels The analgesic effect of millimeter wave (MMW) therapy is due to the release of

The CHU Grenoble research hospital in France has started a clinical trial to evaluate the efficacy of the Remedee Labs

Funding to support new endorphin-stimulation pain therapy clinical trials, including arthritic pain, peri-surgical pain relief and migraine Meylan, France, – 14